Reaction Details |
| Report a problem with these data |
Target | Urokinase-type plasminogen activator |
---|
Ligand | BDBM50101873 |
---|
Substrate/Competitor | n/a |
---|
Meas. Tech. | ChEBML_213158 |
---|
Ki | 110±n/a nM |
---|
Citation | Rai, R; Kolesnikov, A; Li, Y; Young, WB; Leahy, E; Sprengeler, PA; Verner, E; Shrader, WD; Burgess-Henry, J; Sangalang, JC; Allen, D; Chen, X; Katz, BA; Luong, C; Elrod, K; Cregar, L Development of potent and selective factor Xa inhibitors. Bioorg Med Chem Lett11:1797-800 (2001) [PubMed] |
---|
More Info.: | Get all data from this article, Assay Method |
---|
|
Urokinase-type plasminogen activator |
---|
Name: | Urokinase-type plasminogen activator |
Synonyms: | 3.4.21.73 | PLAU | U-plasminogen activator | UROK_HUMAN | Urokinase | Urokinase-type plasminogen activator (uPA) | Urokinase-type plasminogen activator chain B | Urokinase-type plasminogen activator long chain A | Urokinase-type plasminogen activator short chain A | Urokinase-type plasminogen activator/surface receptor | uPA |
Type: | Enzyme |
Mol. Mass.: | 48528.62 |
Organism: | Homo sapiens (Human) |
Description: | P00749 |
Residue: | 431 |
Sequence: | MRALLARLLLCVLVVSDSKGSNELHQVPSNCDCLNGGTCVSNKYFSNIHWCNCPKKFGGQ
HCEIDKSKTCYEGNGHFYRGKASTDTMGRPCLPWNSATVLQQTYHAHRSDALQLGLGKHN
YCRNPDNRRRPWCYVQVGLKLLVQECMVHDCADGKKPSSPPEELKFQCGQKTLRPRFKII
GGEFTTIENQPWFAAIYRRHRGGSVTYVCGGSLISPCWVISATHCFIDYPKKEDYIVYLG
RSRLNSNTQGEMKFEVENLILHKDYSADTLAHHNDIALLKIRSKEGRCAQPSRTIQTICL
PSMYNDPQFGTSCEITGFGKENSTDYLYPEQLKMTVVKLISHRECQQPHYYGSEVTTKML
CAADPQWKTDSCQGDSGGPLVCSLQGRMTLTGIVSWGRGCALKDKPGVYTRVSHFLPWIR
SHTKEENGLAL
|
|
|
BDBM50101873 |
---|
n/a |
---|
Name | BDBM50101873 |
Synonyms: | 2-(3-Bromo-2-hydroxy-5-methyl-phenyl)-1H-indole-5-carboxamidine | 2-{5-[AMINO(IMINIO)METHYL]-1H-INDOL-2-YL}-6-BROMO-4-METHYLBENZENOLATE | CHEMBL48608 |
Type | Small organic molecule |
Emp. Form. | C16H14BrN3O |
Mol. Mass. | 344.206 |
SMILES | Cc1cc(Br)c(O)c(c1)-c1cc2cc(ccc2[nH]1)C(N)=N |
Structure |
|